Gold Eagle Company Promotes Kevin Krueger to CFIO
Formerly the CFO, Krueger will take on additional responsibilities as chief financial & investment officer…
A producer and distributor of performance chemicals and surface treatments, Gold Eagle Company, has announced that CFO Kevin Krueger has been promoted to chief financial and investment officer (CFIO). In his expanded role, Krueger will continue overseeing financial management, IT and legal matters for the company’s brands: STA-BIL, 303, HEET and Hot Shot’s Secret. Additionally, he will now focus on developing the company’s long-term investment strategy and managing corporate investments and acquisitions.
Krueger joined Gold Eagle Company as a controller in 2013 and was promoted to CFO in 2016. With over a decade of experience on various leadership teams, including the Executive Team, IT Steering, Finance, M&A, and Risk Management, Krueger has been recognized by Gold Eagle Company for his commitment to innovation, financial acumen and significant contributions to major company initiatives such as acquisitions.
Gold Eagle Company CEO and board chairman Marc Blackman, says, “Kevin’s business acumen and financial knowledge has helped Gold Eagle Company grow in the face of stiff competition. He has demonstrated exceptional leadership skills and played a pivotal role in 2022 of facilitating Gold Eagle’s acquisition of Lubrication Specialties, manufacturer of Hot Shot’s Secret. His input has been instrumental in the seamless integration of new subsidiaries into the Gold Eagle family.”
Gold Eagle Company manufactures and distributes STA-BIL fuel stabilizers, 303 cleaners and protectants, HEET Gas-Line Antifreeze and Hot Shot’s Secret performance fuel and oil treatments and lubricants to more than 30,000 retail stores, and is the source for many chemical-based private brands.
Krueger is a graduate of the Northern Illinois University College of Business and is a certified public accountant. He is a member of Flourish Advisory Boards, an organization designed to advise C-suite executives and build their leadership skills, and he also serves as a board member for Curing Kids Cancer, a non-profit dedicated to funding pediatric cancer research.
